Captrust Financial Advisors Zynex Inc Transaction History

Captrust Financial Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	SELL	$5.78 - $8.87 $566 - $869	-98 Reduced 10.34%	850 $7,000
Q2 2022 Aug 16, 2022	BUY	$5.78 - $8.87 $5,219 - $8,009	903 Added 2006.67%	948 $8,000
Q1 2022 May 16, 2022	SELL	$5.14 - $9.35 $971 - $1,767	-189 Reduced 80.77%	45 $0
Q3 2021 Nov 16, 2021	SELL	$10.35 - $15.65 $24,343 - $36,808	-2,352 Reduced 90.95%	234 $3,000
Q2 2021 Aug 16, 2021	BUY	$12.25 - $14.87 $6,786 - $8,237	554 Added 27.26%	2,586 $40,000
Q1 2021 May 17, 2021	BUY	$12.28 - $19.74 $24,523 - $39,420	1,997 Added 5705.71%	2,032 $31,000
Q4 2020 Feb 16, 2021	BUY	$11.65 - $17.94 $407 - $627	35 New	35 $0

103

8.4M

200

1.5K

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $293M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.